Hydrocortisone Acetate Suppository
FDA Label NDC 51407-665

15 label sections · Submitted to the FDA by Golden State Medical Supply, Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Golden State Medical Supply, Inc. for the product Hydrocortisone Acetate (NDC 51407-665). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, description:, clinical pharmacology:, indications and usage:, contraindications:, precautions:, carcinogenesis:, pregnancy category c:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Description:

Hydrocortisone acetate is a corticosteroid designed chemically as pregn-4-ene 3, 20-dione, 21-(acetyloxy)-11, 17-dihydroxy––(11 β) with the following structural formula:

Structural Formula (Hemmorex Hc 01)

Structural Formula (Hemmorex Hc 01)

Each rectal suppository contains hydrocortisone acetate, USP 25 mg in a specially blended hydrogenated vegetable oil base.

Clinical Pharmacology:

In normal subjects, about 26% of hydrocortisone acetate is absorbed when the suppository is applied to the rectum. Absorption of hydrocortisone acetate may vary across abraded or inflamed surfaces. Topical steroids are primarily effective because of their anti-inflammatory, anti-pruritic and vasoconstrictive action.

Carcinogenesis:

No long term studies in animals have been performed to evaluate the carcinogenic potential of corticosteroid suppositories.

Adverse Reactions:

The following local adverse reactions have been reported with corticosteroid suppositories; burning, itching, irritation, dryness, folliculitis, hypopigmentation, allergic contact dermatitis, secondary infection.

Overdosage:

If signs and symptoms of systemic overdosage occur, discontinue use.

Dosage And Administration:

For rectal administration. Detach one suppository from strip of suppositories. Remove the wrapper. Avoid excessive handling of the suppository which is designed to melt at body temperature. Insert suppository into the rectum with gentle pressure, pointed end first. Insert one suppository in the rectum twice daily, morning and night for two weeks, in nonspecific proctitis. In more severe cases, one suppository three times a day or two suppositories twice daily. In factitial proctitis, the recommended duration of therapy is six to eight weeks or less, according to the response of the individual case.

All prescription substitutions and/or recommendations using this product shall be made subject to state and federal statutes as applicable. PleaseNOTE: This is notanOrange Book product and hasnot been subjected to FDA therapeutic or other equivalencytesting. No representation is made asto generic status orbioequivalency. Each person recommending a prescription substitution using this product shall make such recommendation based on his/her professional knowledge and opinion, upon evaluating the active ingredients, inactive ingredients, excipients and chemical information provided herein.

* Please review the disclaimer below.